baber/WOPTO huggingface dataset:
Patent PT-1274713-E (PT)
Inventor: MCGUIGAN CHRISTOPHER
IPC: C07H19/23
Filed: 2001-04-12
Abstract: A compound of formula (I) wherein Ar can be one six-membered or two fused six-membered aromatic rings; R8 and R9 can be hydrogen, alkyl, cycloalkyl, halogens, amino, alkylamino, dialkylamino, nitro, cyano, alkyoxy, aryloxy, thiol, alkylthiol, arythiol, or aryl; Q can be O, S or CY2, where Y may be H, alkyl or halogens; X can be O, NH, S, N-alkyl, (CHR2)m where m is 1 to 10, and CY2; Z can be O, S, NH, or N-alkyl; U″ is H and U′ can be H or CH2; wherein: T can be OH, H, halogens, O-alkyl, O-acyl, O-aryl, CN, NH2 or N3; T′ and T″ can be H or halogen; and W can be H or a phosphate group. Compounds show anti-viral activity, for example with respect to varicella zoster virus.
Patent PT-1245744-E (PT)
Inventor: VAROTTI MARIO
IPC: E03D1/14
Filed: 2002-03-27
Abstract: The device (1), which provides for both full and partial discharge, is of the type in which a movable member (11), fitted with a valve (10), has a float (14) for delaying return of the valve to the closed position, and an additional member (31) is selectively connectable to the movable member (11) to accelerate closure of the valve. According to the invention, the additional member (31) is connected to the movable member (11) by a rocking body (40) hinged to a support (38) carried by the additional member (31); and the rocking body (40) has, at respective ends, a buoyancy member (45) and a hook (46) which engages a respective seat (28) on the movable member (11), so that the additional member (31) is connected automatically to the movable member (11) alongside a variation in the level of the water in the tank. <IMAGE>
Patent PT-1265018-E (PT)
Inventor: VIEGENER WALTER
IPC: F16L33/207
Filed: 2002-05-16
Abstract: The connection tube comprises a connection (10) for insertion in a tube (2) and a sector (11) projecting from the tube to connect with it. The connection tube (1) has at least one through aperture (14) which can be sealed by pressing home the tube in the region of the connection. This aperture may be axial or radial.
Patent PT-1283033-E (PT)
Title: Combination of alkylglycoside and pyridine carboxamide
Inventor: RASE DIDIER
IPC: A61K8/67
Filed: 2002-07-24
Abstract: Topical compositions containing alkylosides (I) or their mixtures, and a dermatologically-acceptable carrier.  Topical compositions containing alkylosides of formula (I) or their mixtures, and a dermatologically-acceptable carrier. n  = 0 - 4; R  = (CH2)12, or (CH2)14.
Patent PT-1442023-E (PT)
Title: Crystalline sodium salt of telmisartan and the use of the same as an angiotensin antagonist
Inventor: DONSBACH KAI
IPC: C07D235/20
Filed: 2002-10-11
Abstract: The invention relates to a crystalline sodium salt of 4'-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid (INN: Telmisartan), to a method for the production thereof, and to the use of the same for producing a pharmaceutical having an angiotensin II antagonistic action.
Patent PT-1375707-E (PT)
Title: Activated carbon fibres and their use
Inventor: HEINE MICHAEL
IPC: B01J20/20
Filed: 2003-06-16
Abstract: The activated carbon fiber comprises porous carbon fibers having pores on surface and inside of fibers. The pores are partially filled with solid non-volatile residue made from a carbonized organic polymer.  Independent claims are included for the following:  (1) method of using activated porous carbon fibers; (2) method for making filter module;  (3) production of protective clothing; and  (4) production of activated carbon fibers.
Patent PT-1480734-E (PT)
Title: Device for the preparation and separation of especially biologically organic flow media
Inventor: HILGENDORFF WALTER
IPC: B01D63/08
Filed: 2003-02-26
Abstract: Disclosed is a device (10) for the preparation and separation of especially biologically organic flow media (11) by liquid or gaseous membrane permeation, comprising a stack (12) consisting of a plurality of membrane elements (14) distanced from each other by means of a spacer (13). The flow medium (11) flows around the membrane elements (14) of the stack (12). The permeate (15) delivered by the membrane elements (14) is collected in at least one element (16) traversing the stack (12) and removed externally. The spacer element (13) has a larger dimension (130) in the direction of flow (17) of the medium (11) to be separated than that which is perpendicular to the direction of flow (17).
Patent PT-1606057-E (PT)
Title: A method for the separation of non-ferrous metal containing particles from a particle stream
Inventor: WEIJDEN RENATA DOROTHEA VAN DER
IPC: B03B9/04
Filed: 2004-03-16
Abstract: The invention relates to a method for the recovery of non-ferrous metal-comprising particles from a particle stream. According to the invention, the particle stream is put onto a conveyor belt in the form of a monolayer such that with the aid of a liquid, at least the non-ferrous metal comprising particles will adhere to the conveyor belt, and the mono-layer is subjected to a magnetic field rotating in the same direction as the belt, for the separation of non-ferrous metal-comprising particles, yielding the non-ferrous-enriched fraction, and subsequent to which the metal particles that are not nonferrous adhering to the conveyor belt are removed, yielding the non-ferrous metal-depleted fraction.
Patent PT-1626386-E (PT)
Title: Improved label-bearing section
Inventor: RUIZ FERNANDO ARTERO
IPC: G09F3/20
Filed: 2004-04-16
Abstract: The invention relates to an improved label-bearing section of the type that is used with shelves in commercial establishments and warehouses, in order to support and protect labels containing the prices, characteristics, etc. of the products stored thereon. The invention is  characterised in that  it comprises: separate, independent anchoring elements which are used to fix same to the shelf and to determine the positioning angle of the label; and a double sheet comprising a transparent front part, which is used to house the label and which can move independently of the two anchoring elements. The main advantages offered by the invention lie in the fact that it comprises only one type of label-bearing section which can be fixed to the shelf using various inclination angles which can be eas
Patent PT-1682735-E (PT)
Title: Floor profile arrangement comprising a joint
Inventor: SONDERMANN FRANK
IPC: E04F19/06
Filed: 2004-09-17
Abstract: The floor profile for bridging a gap between adjoining floor coverings etc comprises a base profile (1) and cover profile (3). The cover profile has wings (12, 13) protruding on at least one side. A web unit (2) provides the connection between the base profile and cover profile. An articulation device (7,8) comprises a socket (7) on the base or cover profile and an articulated ball body (8) on the lower or upper edge of the swivel web unit. The articulated body and socket are preferably cylindrical.
Patent PT-1641066-E (PT)
Title: Battery plant of a submarine
Inventor: ANGENENDT HARTMUT
IPC: H01M50/574
Filed: 2005-09-13
Abstract: A battery system for a submarine having at least two battery modules (BM) capable of supplying the network voltage comprises switches (8) connecting each module to the power network that can individually connect/ disconnect the modules to/from the network. An independent claim is also included for a control process for the above that can control the short circuit current on discharging the battery modules.
Patent PT-1726215-E (PT)
Title: Method for the manufacturing of soy and milk protein-based preparations having a high total protein content
Inventor: GEIGER RUPERT
IPC: A23L29/231
Filed: 2005-05-09
Abstract: The present invention concerns a method for manufacturing a protein-enriched food preparation containing soy proteins and milk-derived proteins, said method comprising at least hydration of soy proteins and thickener agent in two different recipients, mixing, adding milk-derived proteins, homogenizing and acidifying the resulting mix. The invention also concerns protein-enriched food preparations obtainable by said method, as well as a method for preparing protein-enriched acidic food products using said preparations, and protein-enriched acidic food products obtainable by this method.
Patent PT-1706865-E (PT)
Title: Apparatus and method for constructing a multi-channel output signal or for generating a downmix signal
Inventor: HERRE JUERGEN
IPC: H04S3/02
Filed: 2005-01-17
Abstract: The apparatus for constructing a multi-channel output signal using an input signal and parametric side information, the input signal including the first input channel and the second input channel derived from an original multi-channel signal, and the parametric side information describing interrelations between channels of the multi-channel original signal uses base channels for synthesizing first and second output channels on one side of an assumed listener position, which are different from each other. The base channels are different from each other because of a coherence measure. Coherence between the base channels (for example the left and the left surround reconstructed channel) is reduced by calculating a base channel for one of those channels by a combination of the input channels, the combination being determined by the coherence measure. Thus, a high subjective quality of the reconstruction can be obtained because of an approximated original front/back coherence.
Patent PT-1818059-E (PT)
Title: Preventive or therapeutic agent for glaucoma
Inventor: KANEBAKO MAKOTO
IPC: A61K31/551
Filed: 2005-12-22
Abstract: A preventing or treating agent for glaucoma or ocular hypertension is provided. This drug has a strong action of reducing intraocularpressure such that the intraocular pressure can be reduced even from the normal intraocular pressure. More specifically, a prophylactic or therapeutic agent for glaucoma, a preventing or treating agent for ocular hypertension, and eye drops comprising (S)-(-)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl homopiperazine or its salt and phosphoric acid or its salt are provided.
Patent PT-1977712-E (PT)
Title: Mobile functional hospital unit for temporarily dispensing medical fluids
Inventor: DENANDO VITTORIO
IPC: A61B19/00
Filed: 2007-04-06
Abstract: The hospital unit (1) has a cabinet (2) housing medical gas bottles, and wheels (12) for displacement. Monitoring and control units provide information about non-functioning of the unit (1) to a user. Rear intakes for sampling medical fluid are connected to a medical fluid distribution network arranged in a hospital building, and are associated to a rear wall of the cabinet. Lateral intakes are associated to lateral walls (27, 28) of the cabinet. A connecting line fluidly connects the gas bottles to the intakes for supplying the intakes with gas delivered by the gas bottles.
Patent PT-2173551-E (PT)
Title: Interlayers comprising stabilized tungsten oxide agents
Inventor: FISHER WILLIAM KEITH
IPC: B32B17/10
Filed: 2008-07-30
Abstract: The present invention includes polymer interlayers that are used in multiple layer glazing panels. Interlayers of the present invention comprise a thermoplastic polymer, a plasticizer, a tungsten oxide agent, and a stabilizing agent that prevents the degradation of the tungsten oxide agent. Interlayers incorporating such components have improved ultraviolet light blocking character, and also maintain optical quality over time.
Patent PT-2330131-E (PT)
Title: Antibodies against her2 truncated variant ctf-611
IPC: G01N33/53
Filed: 2009-12-07
Abstract: The present invention relates to a method of diagnosis and therapy of cancers expressing the HER2 receptor.  The invention provides antibodies or fragments thereof that recognise an epitope of the HER2 receptor truncated form CTF-61 1, said epitope being defined by a sequence included in SEQ ID NO: 2, and that are capable of discriminating between CTF-611 and CTF-616 (represented by SEQ ID NO:7), preferably additionally capable of discriminating between CTF-611 and CTF-613 (represented by SEQ ID NO:6) .  The invention also provides a method of cancer diagnosis using the disclosed antibodies, which comprises the detection of the presence of the HER2 receptor truncated form consisting of the amino acid sequence SEQ ID NO: 1 in a patient sample.
Patent PT-716081-E (PT)
Inventor: MITTENDORF JOACHIM DR
IPC: C07D401/02
Filed: 1995-11-22
Abstract: 2-Benzylidene-3-oxo-butyric acid malimide esters(II), enantiomerically pure aminocrotonic acid malimide esters (IIIa) and enantiomerically pure acetoacetic acid malimide esters (VI) are new. Benzylidene compounds of formula (II), enantiomerically pure aminocrotonic acid esters of formula (IIIa) and enantiomerically pure acetoacetic acid esters of formula (VI) are new. [Image] R2>phenyl substituted by 1 or 2 of halo, CN, ethynyl, OCF3, SMe, NO2, CF3, 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl or 1-4C alkoxy; A : H or 1-8C alkyl; or phenyl or benzyl (both optionally substituted by 1-3 of OH, NO2, halo, CN, COOH, CF3, OCF3 or 1-6C alkoxy or by NR6>R7> or SO2R8>); R6>, R7>H, Ph or 1-5C alkyl; R8>1-4C alkyl or Ph. Independent claims are also included for: (1) the preparation of enatiomerically pure (II), (IIIa) and (VI); and (2) the preparation of diastereomeric 1,4-dihydropyridines of formula (IVa) or (IVb) by: (a) reacting enatiomerically pure (II) with aminocrotonic acid ester of formula Me-C(NH2)=CH-COOR1> (III) in a solvent, optionally in presence of base; or (b) reacting enatiomerically pure (IIIa) with benzylidene compound of formula R2>-CH=C(COMe)-COOR1> (IIa) in a solvent, optionally in presence of base. [Image] R1>1-8C alkyl (optionally substituted by 1-6C alkoxy) or 3-7C cycloalkyl.
Patent PT-730606-E (PT)
Inventor: SNODGRASS RALPH H
IPC: C12Q1/6883
Filed: 1995-08-30
Abstract: The present invention relates to a novel member of the hematopoietin receptor family, herein referred to as Hu-B1.219. In particular, the invention relates to nucleotide sequences and expression vectors encoding Hu-B1.219 gene product. Genetically engineered host cells that express the Hu-B1.219 coding sequence may be used to evaluate and screen for ligands or drugs involved in Hu-B1.219 interaction and regulation. Since Hu-B1.219 expression has been detected in certain human fetal tissues and cancer cells, molecular probes designed from its nucleotide sequence may be useful for prenatal testing and cancer diagnosis.
Patent PT-736170-E (PT)
Inventor: EVANS ROBERT
IPC: B65D25/04
Filed: 1995-10-17
Abstract: Embodiments of the present invention feature a multilchambered cuvette having a first movement pattern and a second movement pattern, the first movement pattern comprises a stationary position and a rotation about a circular path. The second movement pattern comprises a rocking motion. The cuvette uses the first movement of fluid between chambers and a second movement pattern to effect mixing and incubation. The cuvette features a unitary housing having an opening over the first and second compartments to allow viewing and access.
Patent PT-822816-E (PT)
Inventor: KATZ BRUCE E
IPC: A61K31/505
Filed: 1996-04-10
Abstract: A composition for the treatment of actinic keratoses includes 5-fluorouracil and an alpha hydroxy carboxylic acid. The composition may further include ancillary ingredients. A therapeutic method involving the composition and a kit for carrying out the treatment are also disclosed.
Patent PT-869791-E (PT)
Inventor: WEBER ECKARD
IPC: A61K31/551
Filed: 1996-12-20
Abstract: PCT No. PCT/US96/20766 Sec. 371 Date Sep. 16, 1998 Sec. 102(e) Date Sep. 16, 1998 PCT Filed Dec. 20, 1996 PCT Pub. No. WO97/23214 PCT Pub. Date Jul. 3, 1997Novel 4-substituted piperidine analogs, pharmaceutical compositions containing the same and the method of using 4-substituted piperidine analogs as selectively active antagonists of N-methyl-D-aspartate (NMDA) receptor subtypes for treating conditions such as stroke, cerebral ischemia, central nervous system trauma, hypoglycemia, anxiety, convulsions, aminoglycoside antibiotics-induced hearing loss, migraine headaches, glaucoma, CMV retinitis, chronic pain, opioid tolerance or withdrawals, or neurodegenerative disorders, such as lathyrism, Alzheimer's Disease, Parkinsonism and Huntington's Disease are described. Also described are novel methods for preparing 4-substituted piperidine analogs and novel intermediates of the 4-substituted piperidine analogs.
Patent PT-884415-E (PT)
Inventor: HENRICSON KAJ
IPC: D21C/
Filed: 1993-05-25
Abstract: The present invention is directed to a method of washing pulp in connection with bleaching, in which method the pulp is bleached in a first bleaching arrangement, washed in a first washer, bleached in a second bleaching arrangement, and washed in a second washer in such a manner that the washing liquid is recirculated from said second washer to said first washer countercurrent to the pulp flow, characterized in introducing washing liquid to said second washer for washing the pulp coming from said second bleaching arrangement, displacing with said washing liquid at least two different filtrates, collecting said at least two different filtrates separately, and using said at least two filtrates separately upstream of said second washer as washing liquids.
Patent PT-964831-E (PT)
Inventor: HEIJNEN JOSEPH JOHANNES
IPC: C02F3/30
Filed: 1998-02-19
Abstract: The invention relates to a method of acquiring granular growth of a microorganism in a reactor containing a liquid medium. Surprisingly, according to the invention, aerobic microorganisms also can be induced to granular growth by maintaining specific culture conditions. During a first step an oxygen-containing gas is supplied and the reactor contents are kept in turbulence. In a second step, after a short settling period, the top part of the reactor medium is discharged.
Patent PT-1003534-E (PT)
Inventor: LEE PATRICK W K
IPC: A61K35/76
Filed: 1998-08-12
Abstract: There is provided use of a reovirus for the manufacture of a medicament for treating a neoplasm in a mammal, wherein double stranded RNA-activated protein kinase (PKR) is inactivated or deleted in the neoplasm. <IMAGE>
Patent PT-1034111-E (PT)
Inventor: LAKER JONATHAN PAUL
IPC: B65D65/38
Filed: 1998-10-29
Abstract: A boxed end container is shown having one end closed by a transverse ridge seal and carrying a pull tab. The pull tab allows a separating force to be applied to the ridge seal of the sealed container to separate at least part of the ridge seal and thus open the container and allow discharge of its contents. The pull tab is a generally planar member having an axially extending shank member with a proximal end portion which can be gripped and pulled by a user and a distal end portion having foot members extending transversely to each side of thereof. The shank and foot members are substantially co-planar with one another. The pull tab is secured by the foot members externally to a wall of the container at or adjacent to the ridge seal of the container.
Patent PT-1104547-E (PT)
Inventor: FREI ULRICH
IPC: G01N33/82
Filed: 1999-08-11
Abstract: The invention relates to an in vitro method of recognizing acute coronary syndroms, especially an acute myocardial infarction, by determining and evaluating the content of choline, choline and/or trimethyl ammonium derivatives selected from the group comprising phosphoryl choline, plasmalogens, and lysoplasmenyl choline, and/or the reaction products thereof selected from the group comprising 1-O-alk-1'-enyl-2 substituted glycerol and 1-O-alk-1'-enyl-2 substituted glycerol phosphate in body fluids or component parts of the body, said method comprising the following steps:drawing a sample of a suitable body fluid or component part of the body; determining the content of choline, choline and/or trimethyl ammonium derivatives selected from the group comprising phosphoryl choline, plasmalogens, and lysoplasmenyl choline, and/or the reaction products thereof selected from the group comprising 1-O-alk-1'-enyl-2 substituted glycerol and 1-O-alk-1'-enyl-2 substituted glycerol phosphate by a suitable method of determination (nuclear magnetic resonance methods, biochemical, enzymatic, immunological, clinical-chemical, chromatographic, mass spectrometric, electrochemical, photometric methods, or other methods); and evaluating the measured results, taking into account a limit value for recognition or exclusion of acute coronary syndroms, especially an acute myocardial infarction.
Patent PT-1108271-E (PT)
Inventor: BIRKE PETER
IPC: H01M4/04
Filed: 1999-08-27
Abstract: The invention relates to a paste-like mass that can be used in electrochemical elements comprising a matrix comprising at least one organic polymer, precursors thereof, or prepolymers thereof, and an electrochemically activatable inorganic material that is not soluble in the matrix and that is in the form of a solid substance, whereby either (a) the mass comprises at least 60 vol. % (B) and, if (B) is an electrode material, (B) is worked into the matrix (A) without the assistance of a solvent or swelling agent or the matrix (A) also contains a plasticizer for the organic polymer, and the plasticizer is subsequently removed using a suitable solvent, (C) and/or (c) the mixture also contains a solid ion electron and/or mixed conductor that is different from (B) and that is present at least at the grain limits between (A) and (B) as a thin layer.
Patent SG-39585-G (SG)
Title: Optical fibre joints in overhead electric transmission systems
IPC: G02B6/04
Filed: 1985-05-29
Abstract: In an overhead electric transmission system in which the phase conductors incorporate optical fibres, a joint between optical fibres of two phase conductors or between optical fibres of a phase conductor and an optical cable extending to a sub-station is enclosed within a fluid-tight metal housing. The housing is electrically connected to each phase conductor, is electrically insulated from earth, and has an external shape of such a form as to provide effective control of electrical stress. Preferably the metal housing is of hemi-spherical shape and is mounted on top of a porcelain insulator containing oil under pressure. Where an optical fibre connected at the joint is that of an optical cable, it passes into the metal housing through the oil filled porcelain insulator.
Patent SG-55093-G (SG)
Title: Combination dosage form for premenopausal women
IPC: A61K31/565
Filed: 1993-04-29
Abstract: Disclosed herein is a method of providing hormonal replacement therapy and contraception for a pre-menopausal woman, which comprises administering to a pre-menopausal woman in need thereof a combination dosage form of an estrogen selected from  0.5-2.0 mg. of 17 beta -estradiol,  0.008-0.030 mg. of ethinyl estradiol, and  0.015-0.060 mg. of mestranol;  and a progestogen selected from  0.025-0.100 mg. of levonorgestrel,  0.010-0.070 mg. of gestodene,  0.025-0.100 mg. of desogestrel,  0.025-0.100 mg. of 3-ketodesogestrel, and  0.085-0.35 mg. of norethindrone, said combination dosage form being administered for 23-25 days beginning at day one of the menstrual cycle, followed by 2-5 pill-free or blank pill days, for a total of 28 days in the administration cycle. The preferred dosage form of the invention is a combination of 1 mg. of 17 beta -estradiol and 0.050 or 0.075 mg. of levonorgestrel. The preferred administration cycle of the invention is administration of the combination dosage form for the first 24 days of the menstrual cycle and no dosage form for the last 4 days of the menstrual cycle.